- Research article
- Open Access
Role of sgcR3 in positive regulation of enediyne antibiotic C-1027 production of Streptomyces globisporus C-1027
© Wang et al; licensee BioMed Central Ltd. 2009
Received: 11 September 2008
Accepted: 22 January 2009
Published: 22 January 2009
C-1027, produced by Streptomyces globisporus C-1027, is one of the most potent antitumoral agents. The biosynthetic gene cluster of C-1027, previously cloned and sequenced, contains at least three putative regulatory genes, i.e. sgcR1, sgcR2 and sgcR3. The predicted gene products of these genes share sequence similarities to StrR, regulators of AraC/XylS family and TylR. The purpose of this study was to investigate the role of sgcR3 in C-1027 biosynthesis.
Overexpression of sgcR3 in S. globisporus C-1027 resulted in a 30–40% increase in C-1027 production. Consistent with this, disruption of sgcR3 abolished C-1027 production. Complementation of the sgcR3-disrupted strain R3KO with intact sgcR3 gene could restore C-1027 production. The results from real time RT-PCR analysis in R3KO mutant and wild type strain indicated that not only transcripts of biosynthetic structural genes such as sgcA1 and sgcC4, but also putative regulatory genes, sgcR1 and sgcR2, were significantly decreased in R3KO mutant. The cross-complementation studies showed that sgcR1R2 could functionally complement sgcR3 disruption in trans. Purified N-terminal His10-tagged SgcR3 showed specific DNA-binding activity to the promoter region of sgcR1R2.
The role of SgcR3 has been proved to be a positive regulator of C-1027 biosynthesis in S. globisporus C-1027. SgcR3 occupies a higher level than SgcR1 and SgcR2 in the regulatory hierarchy that controls C-1027 production and activates the transcription of sgcR1 and sgcR2 by binding directly to the promoter region of sgcR1R2.
C-1027, also called lidamycin, is a chromoprotein antitumor antibiotic produced by Streptomyces globisporus C-1027 . As a member of the enediyne family characterized by two acetylenic groups conjugated to a double bond within a 9- or 10-membered ring, C-1027 is 1,000 times more potent than adriamycin, one of the most effective chemotherapeutic agents . C-1027 is a complex consisting of a 1:1 non-covalently associated mixture of an apoprotein and a 9-membered enediyne chromophore. The chromophore of the enediyne family can undergo a rearrangement to form a transient benzenoid diradical species that can abstract hydrogen atoms from DNA to initiate a cascade leading to DNA breaks, ultimately leading to cell death [3, 4]. This novel mode of action has attracted great interest in developing these compounds into therapeutic agents for cancer. A CD33 monoclonal antibody (mAB)-calicheamicin (CAL) conjugate (Mylotarg) and neocarzinostatin (NCS) conjugated with poly (styrene-co-maleic acid) (SMANCS) were approved in the USA  and in Japan , respectively. Recently, C-1027 has entered phase II clinical trial in China . Appreciation of the immense pharmacological potential of enediynes has led to a demand for the economical production of C-1027 and its analogues at an industrial scale.
Control of secondary metabolite production in streptomycetes and related actinomycetes is a complex process involving multiple levels of regulation in response to environmental factors [For review, see [8, 9]]. In most cases that have been studied in detail, the final checkpoint in production of a secondary metabolite is a pathway-specific transcriptional regulatory gene situated in the biosynthetic cluster. Remarkable progress has been made in dissecting the functions of the pathway-specific regulators. For example, ActII-ORF4 regulates transcription from the actinorhodin biosynthetic genes of S. coelicolor [10, 11] and StrR controls the streptomycin biosynthetic cluster of S. griseus [12, 13]. Recently, along with the tremendous increase in sequence information for secondary metabolic gene clusters, more and more clusters with multiple cluster-situated regulators were reported (e.g., [14–17]). The best studied multiple pathway-specific regulatory cascade involves remarkably five regulatory genes in tylosin biosynthetic gene cluster of S. fradiae, and a model for their regulation has been proposed [14, 18–23]. Deciphering the complexity of these pathway-specific regulatory networks is of great interest not only for better understanding of the antibiotic regulatory mechanism, but also for providing new strategy for targeted genetic engineering of antibiotic producing strains.
Hereby we investigated the role of sgcR3 in C-1027 biosynthesis, and provided an initial understanding of pathway-specific regulatory network of sgcR1, sgcR2 and sgcR3 in S. globisporus C-1027.
Overexpression of sgcR3 increased the production of C-1027
Inactivation and complementation of sgcR3
To confirm that the disruption of sgcR3 was indeed responsible for the abolition of C-1027 production, the mutant was complemented with sgcR3 gene. Three sgcR3 expression plasmids (pKCR3, pSETR3 and pLR3) were introduced into R3KO mutant by conjugation respectively. pSETR3 and pLR3, both based on the plasmid pSET152  integrating into the ΦC31 attB site on the chromosome, had a copy of sgcR3 controlled by its native promoter and a strong constitutive promoter ermE*p respectively. The resultant strains with pKCR3 (Fig. 4D, c) and pSETR3 (Fig. 4D, d) restored the C-1027 production and showed dose proportionality as expected. The strain containing pLR3 in which sgcR3 was controlled by ermE*p showed less production of C-1027 (Fig. 4D, e) compared with the strain containing pSETR3. No production of C-1027 was detected for the R3KO mutants transformed with pKC1139 and pSET152 (data not shown). These results, fully consistent with those obtained upon overexpression of sgcR3 gene, confirmed the positive regulatory role of sgcR3 in C-1027 biosynthesis.
Gene expression analysis in R3KO mutant
In trans complementation of R3KO mutant with sgcR1R2
Binding of SgcR3 to the sgcR1R2 promoter region
To be a transcriptional activator of C-1027 biosynthesis, SgcR3 was speculated that it may act as a positive regulator by binding at or near the promoter region of biosynthetic genes or regulatory genes and thereby activating their transcription. EMSA were carried out to verify whether SgcR3 indeed had DNA-binding activity, using the purified His10-tagged SgcR3 and selected DNA fragments from the biosynthetic gene cluster of C-1027. Eight intergenic regions of interest are chosen for EMSA, including upstream region of sgcA1, sgcB1, sgcC1, sgcD2, sgcK, cagA, sgcR3 and sgcR1R2 (Fig. 7B). The results showed that the recombinant SgcR3 protein had binding activity to the 455 bp upstream fragment of the sgcR1R2, but not for any other of the eight DNA fragments investigated. Further EMSA carried out using different concentration of purified recombinant SgcR3 showed that the shift band emerged along with the increase of the protein amount. Shifting of the labelled probe was not observed when the corresponding unlabelled probes were added in excess to binding reaction (Fig. 7C). Specific binding of SgcR3 to the upstream fragment of the sgcR1R2 in vitro, together with the results of gene expression analysis and sgcR1R2 cross-complementation in R3KO mutant, indicated that SgcR3 activates the transcription sgcR1R2 directly by binding to its promoter region.
The original sequence analysis of the C-1027 biosynthetic gene cluster identified several ORFs whose gene products may have a potential regulatory function . We focused our initial study on the sgcR3 gene situated at the right end of the cluster. Overexpression studies with additional copies of sgcR3 expressed under the control of its native promoter in wild type strain indicated a positive effect on C-1027 production. The results obtained in the gene disruption experiment clearly demonstrated the essential positive role of sgcR3 in regulation of C-1027 biosynthesis.
The results obtained in sgcR3 inactivation experiments were proved by complementation of the R3KO mutant using different strategies to express sgcR3 in trans. The results showed that expression of sgcR3 under the control of its native promoter either introduced by a multi-copy plasmid or integrated into the ΦC31 attB site on the chromosome fully restored C-1027 production. Unexpectedly, the complementation of sgcR3 under strong constitutive promoter ermE*p produced less C-1027 than under its native promoter, suggesting that the promoter region of sgcR3 was intricately regulated for its timing or the amount of expression which was important for the C-1027 production. One possibility is that there is a positive feedback mechanism controlling the expression of sgcR3, e.g., SgcR1 and/or SgcR2 can activate the expression of sgcR3 in return.
Analysis of gene expression in the mutant and wild type strain suggested that sgcR3 control C-1027 production through transcriptional regulation of biosynthetic genes. It also helped to establish a hierarchy among the three regulators of the C-1027 gene cluster. The expression level of sgcR1 and sgcR2 was significantly lower in R3KO mutant than in wild type strain, implying that sgcR3 occupied a higher rung than sgcR1 and sgcR2 did in the hierarchy of C-1027 regulatory genes. Only TylR among SgcR3 orthologues was characterized by gene disruption, in vivo complementation and gene expression experiments [14, 23]. Overexpression of TylR was experimentally proved to increase tylosin yield by 60–70% . According to these studies, TylR occupies the lowest level in the genetic hierarchy that controls tylosin production in S. fradiae, but that was probably not the case of SgcR3 for C-1027 production in S. globisporus C-1027.
Additional evidence for a correlation between these regulators of biosynthesis was observed through the study of cross-complementation experiment. The sgcR1R2 functionally complemented R3KO mutant under either its native promoter or strong constitutive promoter ermE* p. Furthermore, the recombinant SgcR3 protein bound specifically to the promoter region of sgcR1R2, but not that of sgcR3 and some structural genes detected. Therefore, it was very likely that SgcR3 activated the transcription of sgcR1 and sgcR2 by directly binding to their promoter region, to control the expression of biosynthetic structural genes indirectly. On the other hand, although the recombinant SgcR3 can bind to sgcR1R2 promoter region DNA fragment without further macromolecular factor in vitro, our results do not completely rule out the possibility that other protein(s) may be required for activating the transcription of sgcR1R2.
With few except that no regulatory gene present in the biosynthetic gene cluster, e.g., erythromycin cluster of Saccharopolyspora erythraea , most much-studied antibiotic gene clusters contain at least one pathway-specific regulator. However, the biosynthesis of more complex molecules may need more regulatory gene products involving a regulatory cascade to affect a positive or negative regulation. Some particularly interesting examples are the tylosin biosynthetic gene cluster of S. fradiae [14, 18, 19, 21–23] and the rapamycin biosynthetic gene cluster of S. hygroscopicus  which contain, remarkably, no fewer than five putative regulatory genes. Further analysis of other ORFs in C-1027 gene cluster revealed that additional three unknown genes might have regulatory role in C-1027 biosynthesis. The sgcE1 encodes a protein homologous (43% end-to-end identity) to a transcriptional regulator of HxlR family (GenBank accession no. ABX37987). The sgcR encodes a protein demonstrating some homology (20% end-to-end identity) to a transcriptional regulator protein (GenBank accession no. EDS60418) which belongs to XRE (Xenobiotic Response Element) family. The deduced product of sgcM was also found to be highly similar to a putative DNA-binding protein of S. coelicolor A3(2) with a helix-turn-helix motif (GenBank accession no. NP_630506.1). Both sgcE1 and sgcM have a highly homologous counterpart in NCS biosynthetic gene cluster of S. carzinostaticus. This is not surprising due to the complicated biosynthesis of enediyne chromophore, which involves multiple moieties and a convergent biosynthetic approach used to piece together the final product.
The available evidence demonstrated that SgcR3 was a transcriptional activator in C-1027 biosynthesis. Also, sgcR3 was demonstrated to occupy a higher level than sgcR1 and sgcR2 does in the regulatory cascade of C-1027 biosynthesis in S. globisporus C-1027 and activate the transcription of sgcR1R2 by directly binding to its promoter region.
Strains, media and growth conditions
E. coli DH5α was used as host for cloning experiments. E. coli ET12567/pUZ8002  was used to transfer DNA into S. globisporus by conjugation. E. coli BL21 (DE3) (Novagen, Madison, USA) was used to express SgcR3 protein. They were grown either on solid or in liquid Luria-Bertani medium (LB) at 37°C. The following antibiotics were used to select recombinant E. coli strains: 100 μg ampicillin (Ap) ml-1, 50 μg kanamycin (Km) ml-1, 25 μg chloramphenicol (Cm) ml-1 or 50 μg apramycin (Am) ml-1. B. subtilis CMCC(B) 63501 was used as the test organism for assay of the antibacterial activity of C-1027 , grown on solid F403 agar (consisting of 0.5% peptone, 0.3% beef extract, 0.3% K2HPO4 and 1.5% agar (pH 7.8)) at 37°C.
Bacterial strains and plasmids used in this study
Strains or plasmids
Escherichia coli DH5α
General cloning host
E. coli ET12567/pUZ8002
Strain used for E. coli/Streptomyces conjugation
E. coli BL21 (DE3)
Strain used for the expression of SgcR3 protein
Bacillus subtilis CMCC(B) 63501
Strain used for C-1027 bioassays
Streptomyces globisporus C-1027
Wild type C-1027 producing strain
S. globisporus R3KO
S. globisporus C-1027 with disruption of sgcR3, Thr
General cloning vector, Apr
E. coli expression vector, Apr
E. coli/Streptomyces shuttle vector, Amr
Suicide vector nonreplicating in Streptomyces, Amr
Streptomyces integrative vector, Amr
pSET152 derivative plasmid containing ermE* p and the ribosome-binding site of the tuf1 gene upstream atrAc gene, Amr
pOJ260 derivative plasmid with the disruption of sgcR3, Thr
pKC1139 derivative plasmid containing 2,539 bp fragment of sgcR3 including its native promoter, Amr
pSET152 derivative plasmid containing 2,539 bp fragment of sgcR3 including its native promoter, Amr
pL646 derivative plasmid containing 1,188 bp coding region of sgcR3 instead of atrAc, Amr
pKC1139 derivative plasmid containing 2,461 bp fragment of sgcR1R2 including its native promoter, Amr
pKC1139 derivative plasmid containing 2,461 bp fragment of sgcR1R2 under the ermE* p, Amr
PCR primers used in this study
Forward and reverse primers for amplifying 1.4 kbp upstream arm used in knockout of sgcR3
Forward and reverse primers for amplifying 1.4 kbp downstream arm used in knockout of sgcR3
Forward and reverse primers for amplifying 2,539 bp sgcR3 including its native promoter
Forward and reverse primers for amplifying 1,188 bp sgcR3 coding region
Forward and reverse primers for amplifying 2,461 bp sgcR1R2 including its native promoter
Forward and reverse primers used for the detection of hrdB transcripts
Forward and reverse primers used for the detection of sgcR1 transcripts
Forward and reverse primers used for the detection of sgcR2 transcripts
Forward and reverse primers used for the detection of sgcR3 transcripts
Forward and reverse primers used for the detection of sgcA1 transcripts
Forward and reverse primers used for the detection of sgcC4 transcripts
Forward and reverse primers for amplifying 438 bp upstream of sgcA1
Forward and reverse primers for amplifying 496 bp upstream of sgcB1
Forward and reverse primers for amplifying 481 bp upstream of sgcC1
Forward and reverse primers for amplifying 448 bp upstream of sgcD2
Forward and reverse primers for amplifying 471 bp upstream of sgcK
Forward and reverse primers for amplifying 455 bp upstream of sgcR1R2
Forward and reverse primers for amplifying 467 bp upstream of sgcR3
Forward and reverse primers for amplifying 429 bp upstream of cagA
Construction of expression plasmids
Three plasmids for sgcR3 expression were constructed as follows. The sgcR3 with its promoter region (2,539 bp) was amplified by PCR and then cloned into the E. coli/Streptomyces shuttle vector pKC1139  to give pKCR3. The fragment was also ligated into an integrative vector pSET152  to give pSETR3. The sgcR3 coding region (1,188 bp) amplified by PCR was introduced to pL646 , displacing atrAc gene under the control of a strong constitutive promoter ermE*p, to give pLR3.
Similarly, sgcR1R2 (2,461 bp) with its promoter region were amplified by PCR and cloned into pKC1139 vector to yield pKCR1R2. This fragment was also cloned into pKC1139 under the control of ermE*p, resulting in plasmid pKCER1R2.
Disruption of sgcR3
The disruption construct consists of a thiostrepton resistant gene (tsr), sandwiched between two PCR products ("arms") that each contains sequence from sgcR3 plus flanking DNA. The arms (which were authenticated by sequence analysis) were of approximately equal size (1.4 kbp).
The primers for sgcR3 disruption introduced restriction sites into the arms (Eco RI and Bgl II in the upstream arm, Bgl II and Hin dIII in the downstream arm), and thus allowed fusion at the Bgl II sites by ligation into pUC18. Then, the tsr fragment (a 1 kbp Bcl I restriction fragment from pIJ680 ) was introduced into the Bgl II site and thereby displaced 507 bp of sgcR3. Disrupted sgcR3 plus flanking DNA (approximate 3.8 kbp in total) was ligated into suicide plasmid pOJ260  to give pOJR3KO. This plasmid was introduced by transformation into E. coli ET12567/pUZ8002 and then transferred into S. globisporus C-1027 by conjugation. Double-crossover exconjugants were selected on MS agar containing Th and Am (Thr, Ams). Deletions within sgcR3 were confirmed by PCR and Southern blot hybridization.
Gene expression analysis by real time reverse transcriptase PCR (RT-PCR)
RNA was isolated from S. globisporus mycelia scraped from cellophane laid on the surface of S5 agar plates, treated with DNaseI (Promega, WI, USA) and quantitated as described previously [37, 38]. The first strand synthesis of cDNA was performed with SuperScript III First-strand Synthesis System (Inivitrogen, CA, USA) using 2 μg total RNA and the random hexamers as primers following the manufacturer's instructions. Oligonucleotides were designed to amplify fragments of about 100–150 bp from the target genes (Table 2).
Quantitative real time PCR of selected genes was performed using the SYBR Green PCR Master Mix (ABI, Cheshire, UK). To control for genomic DNA contamination, each sample was also incubated with a reaction mixture that lacked RT. Real time PCR conditions were as follows: 94°C for 10 min, 40 cycles of 94°C for 30 s, 60°C for 30 s and 72°C for 30 s. A step of 78°C for 10 s during which fluorescence was measured was included at the end of each cycle. The reactions were subjected to a heat dissociation protocol after the final cycle of PCR to indicate the proper temperature for fluorescence detection. After PCR amplifications, data were analyzed with iQ5 Optical System version 1.1.1442.0 Software (Bio-Rad). The threshold cycle (Ct) was calculated from the programme. Serial dilution of the cDNA was subjected to real time PCR. For each transcript, plots of Log2(dilution factor) against the Ct values provided an estimate of the efficiency of the amplification. The target gene mRNA level were normalised internally to the level of hrdB mRNA according to the Pfaffl's method .
C-1027 production and analysis
For C-1027 production, S. globisporus strains were grown in liquid medium FMC-1027-1 by a two-stage fermentation. The spore suspensions of the different strains were adjusted to the same concentration for inoculation. The seed inoculum was prepared by inoculating 100 ml of FMC-1027-1 with an aliquot of the spore suspension and incubating the mixture at 28°C and 250 rpm for 2 days. The seed culture (5%) was added to a fresh 100 ml of FMC-1027-1, continuing to incubate at 28°C and 250 rpm for 5 days. To obtain statistically significant results, each strain was represented by a triplicate sample set. Dry weight of mycelia was measured in cultures taken at different time points in the fermentation course and the pattern of growth curves were monitored consistently among the relevant strains. The production of C-1027 was analyzed using the fermentation supernatants of relevant strains with the same growth curves.
C-1027 production was detected by assaying its antibacterial activity against B. subtilis . The fermentation supernatant (180 μl) was added to stainless steel cylinders placed on F403 agar plate containing B. subtilis spores (0.4% v/v). C-1027 production was estimated by measuring the sizes of the inhibition zones after incubated at 37°C for 12 h.
Isolation and high-pressure liquid chromatography (HPLC) analysis of C-1027 chromophore were carried out mostly following Liu et al. . Briefly, (NH4)2SO4 was added to the 250 ml fermentation supernatant of relevant strains to 100% saturation and then adjusted to pH 4.0 with 0.1 M HCl. The precipitated C-1027 chromoprotein was dissolved in 15 ml 0.1 M potassium phosphate (pH 8.0). The supernatant was then extracted with 50 ml ethyl acetate (EtOAc), concentrated in vacuum, and re-dissolved in 250 μl methanol. 25 μl cleared sample was subjected to HPLC on a Kromasil C-18 column (5 μm, 150 × 4.6 mm, Bohus, SE), eluted isocratically with 20 mM potassium phosphate (pH 6.86)/CH3CN (50:50, v/v) at a flow rate of 1.0 ml/min and detected by monitoring UV absorbance at 350 nm. The C-1027 enediyne chromophore standard for HPLC analysis was confirmed by ESI-MS.
Expression and purification of His10-tagged SgcR3
The sgcR3 coding sequence was PCR-amplified from S. globisporus C-1027 genome DNA containing an Nde I and Bam HI restriction sites, and then ligated into pET-16b (Novagen, Madison, USA), authenticated by sequencing, and then transformed into the E. coli BL21 (DE3). For production of His10-tagged SgcR3, cultures (800 ml; OD600 = 0.6) were induced with IPTG (0.05 mM final), incubated at 28°C for 6 h, harvested by centrifugation. The cell suspension was sonicated for 60 × 10 s with 10 s intervals between each treatment in 30 ml lysis buffer (50 mM NaH2PO4, pH 8.0, 300 mM NaCl, 10 mM imidazole, 2 mg lysozyme ml-1). Cellular debris was removed by centrifugation (12,000 rpm for 10 min). His10-tagged SgcR3 was then affinity purified using HisTrap™ FF crude (Amersham Biosciences) according to the manufacturer's directions and fractions eluted from the column were analysed on SDS-12% w/v polyacrylamide gels. Those fractions containing recombinant protein were pooled, dialysed overnight at 4°C against dialysis buffer (25 mM Tris/HCl (pH 7.5), 10% (w/v) glycerol, 2 mM DTT) and stored at -70°C. The BCA™ Protein Assay Kit (Pierce Biotechnology, Rockfold, USA) was used for protein quantification with bovine serum albumin as the standard.
Electrophoretic mobility shift analysis (EMSA)
DNA fragments upstream of sgcR1R2, sgcR3, sgcA1, sgcB1, sgcC1, sgcD2, sgcK and cagA were generated by PCR using S. globisporus C-1027 genomic DNA as template. Primers are shown in Table 2. After purification by agarose electrophoresis, these DNA fragments were 3'-end labelled with Biotin-11-ddUTP using the Biotin 3' End DNA Labeling Kit (Pierce Biotechnology). Probes were incubated at 4°C for 20 min with purified His10-SgcR3 protein in binding buffer (100 mM Tris/HCl (pH 7.5), 500 mM KCl, 10 mM DTT). Reaction mixtures were then analysed by non-denaturing PAGE (5% w/v gels) in 0.5 × TBE buffer at 4°C. The gel was then transferred to nylon membrane (Amersham Biosciences) by electrophoretic transfer. The biotin end-labeled DNA was detected by LightShift Chemiluminescent EMSA Kit (Pierce Biotechnology) according to the manufacturer's instructions.
The authors gratefully acknowledge Dr. K. McDowall for providing the plasmid pL646 and Dr. Wen Liu for stimulating discussions. We also thank Prof. Lianfang Jin for technical assistance in HPLC analysis of C-1027. This work was funded by grants from the National Natural Science Foundation of China (30572274) and Ministry of Science and Technology of China (2006AA02Z223) to BH. Supports from Ministry of Education of China (NCET-06-0157) to BH are also gratefully acknowledged.
- Hu JL, Xue YC, Xie MY, Zhang R, Otani T, Minami Y, Yamada Y, Marunaka T: A new macromolecular antitumor antibiotic, C-1027. I. Discovery, taxonomy of producing organism, fermentation and biological activity. J Antibiot (Tokyo). 1988, 41: 1575-1579.View ArticleGoogle Scholar
- Zhen YS, Ming XY, Yu B, Otani T, Saito H, Yamada Y: A new macromolecular antitumor antibiotic, C-1027. III. Antitumor activity. J Antibiot (Tokyo). 1989, 42: 1294-1298.View ArticleGoogle Scholar
- Dedon PC, Goldberg IH: Sequence-specific double-strand breakage of DNA by neocarzinostatin involves different chemical mechanisms within a staggered cleavage site. J Biol Chem. 1990, 265: 14713-14716.PubMedGoogle Scholar
- Smith AL, Nicolaou KC: The enediyne antibiotics. J Med Chem. 1996, 39: 2103-2117. 10.1021/jm9600398.PubMedView ArticleGoogle Scholar
- Bross PF, Beitz J, Chen G, Chen XH, Duffy E, Kieffer L, Roy S, Sridhara R, Rohman A, Williams G: Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin Cancer Res. 2001, 7: 1490-1496.PubMedGoogle Scholar
- Maeda H, Edo K, Ishida NE: Neocarzinostatin: The Past, Present, and Future of an Anticancer Drug. 1997, NY: Springer-VerlagView ArticleGoogle Scholar
- Shao RG, Zhen YS: Enediyne anticancer antibiotic lidamycin: chemistry, biology and pharmacology. Anticancer Agents Med Chem. 2008, 8: 123-131. 10.2174/187152008783497055.PubMedView ArticleGoogle Scholar
- Bibb MJ: Regulation of secondary metabolism in streptomycetes. Curr Opin Microbiol. 2005, 8: 208-215. 10.1016/j.mib.2005.02.016.PubMedView ArticleGoogle Scholar
- Champness WC: Actinomycete development, antibiotic production, and phylogeny: questions and challenges. Prokaryotic Development. Edited by: Brun YV, Shimkets LJ. 2000, Washington DC, American Society for Microbiology, 11-31.View ArticleGoogle Scholar
- Fernandez-Moreno MA, Caballero JL, Hopwood DA, Malpartida F: The act cluster contains regulatory and antibiotic export genes, direct targets for translational control by the bldA tRNA gene of Streptomyces. Cell. 1991, 66: 769-780. 10.1016/0092-8674(91)90120-N.PubMedView ArticleGoogle Scholar
- Arias P, Fernandez-Moreno MA, Malpartida F: Characterization of the pathway-specific positive transcriptional regulator for actinorhodin biosynthesis in Streptomyces coelicolor A3(2) as a DNA-binding protein. J Bacteriol. 1999, 181: 6958-6968.PubMed CentralPubMedGoogle Scholar
- Retzlaff L, Distler J: The regulator of streptomycin gene expression, StrR, of Streptomyces griseus is a DNA binding activator protein with multiple recognition sites. Mol Microbiol. 1995, 18: 151-162. 10.1111/j.1365-2958.1995.mmi_18010151.x.PubMedView ArticleGoogle Scholar
- Tomono A, Tsai Y, Yamazaki H, Ohnishi Y, Horinouchi S: Transcriptional control by A-factor of strR, the pathway-specific transcriptional activator for streptomycin biosynthesis in Streptomyces griseus. J Bacteriol. 2005, 187: 5595-5604. 10.1128/JB.187.16.5595-5604.2005.PubMed CentralPubMedView ArticleGoogle Scholar
- Bate N, Butler AR, Gandecha AR, Cundliffe E: Multiple regulatory genes in the tylosin biosynthetic cluster of Streptomyces fradiae. Chem Biol. 1999, 6: 617-624. 10.1016/S1074-5521(99)80113-6.PubMedView ArticleGoogle Scholar
- Knirschova R, Novakova R, Feckova L, Timko J, Turna J, Bistakova J, Kormanec J: Multiple regulatory genes in the salinomycin biosynthetic gene cluster of Streptomyces albus CCM 4719. Folia Microbiol (Praha). 2007, 52: 359-365. 10.1007/BF02932090.View ArticleGoogle Scholar
- Kuscer E, Coates N, Challis I, Gregory M, Wilkinson B, Sheridan R, Petkovic H: Roles of rapH and rapG in positive regulation of rapamycin biosynthesis in Streptomyces hygroscopicus. J Bacteriol. 2007, 189: 4756-4763. 10.1128/JB.00129-07.PubMed CentralPubMedView ArticleGoogle Scholar
- Sekurova ON, Brautaset T, Sletta H, Borgos SE, Jakobsen MO, Ellingsen TE, Strom AR, Valla S, Zotchev SB: In vivo analysis of the regulatory genes in the nystatin biosynthetic gene cluster of Streptomyces noursei ATCC 11455 reveals their differential control over antibiotic biosynthesis. J Bacteriol. 2004, 186: 1345-1354. 10.1128/JB.186.5.1345-1354.2004.PubMed CentralPubMedView ArticleGoogle Scholar
- Bate N, Stratigopoulos G, Cundliffe E: Differential roles of two SARP-encoding regulatory genes during tylosin biosynthesis. Mol Microbiol. 2002, 43: 449-458. 10.1046/j.1365-2958.2002.02756.x.PubMedView ArticleGoogle Scholar
- Bate N, Bignell DR, Cundliffe E: Regulation of tylosin biosynthesis involving 'SARP-helper' activity. Mol Microbiol. 2006, 62: 148-156. 10.1111/j.1365-2958.2006.05338.x.PubMedView ArticleGoogle Scholar
- Bate N, Cundliffe E: The mycinose-biosynthetic genes of Streptomyces fradia e, producer of tylosin. J Ind Microbiol Biotechnol. 1999, 23: 118-122. 10.1038/sj.jim.2900707.PubMedView ArticleGoogle Scholar
- Bignell DR, Bate N, Cundliffe E: Regulation of tylosin production: role of a TylP-interactive ligand. Mol Microbiol. 2007, 63: 838-847. 10.1111/j.1365-2958.2006.05541.x.PubMedView ArticleGoogle Scholar
- Stratigopoulos G, Cundliffe E: Expression analysis of the tylosin-biosynthetic gene cluster: pivotal regulatory role of the tylQ product. Chem Biol. 2002, 9: 71-78. 10.1016/S1074-5521(01)00095-3.PubMedView ArticleGoogle Scholar
- Stratigopoulos G, Bate N, Cundliffe E: Positive control of tylosin biosynthesis: pivotal role of TylR. Mol Microbiol. 2004, 54: 1326-1334. 10.1111/j.1365-2958.2004.04347.x.PubMedView ArticleGoogle Scholar
- Liu W, Shen B: Genes for production of the enediyne antitumor antibiotic C-1027 in Streptomyces globisporus are clustered with the cagA gene that encodes the C-1027 apoprotein. Antimicrob Agents Chemother. 2000, 44: 382-392. 10.1128/AAC.44.2.382-392.2000.PubMed CentralPubMedView ArticleGoogle Scholar
- Liu W, Christenson SD, Standage S, Shen B: Biosynthesis of the enediyne antitumor antibiotic C-1027. Science. 2002, 297: 1170-1173. 10.1126/science.1072110.PubMedView ArticleGoogle Scholar
- Ahlert J, Shepard E, Lomovskaya N, Zazopoulos E, Staffa A, Bachmann BO, Huang K, Fonstein L, Czisny A, Whitwam RE, Farnet CM, Thorson JS: The calicheamicin gene cluster and its iterative type I enediyne PKS. Science. 2002, 297: 1173-1176. 10.1126/science.1072105.PubMedView ArticleGoogle Scholar
- Liu W, Nonaka K, Nie L, Zhang J, Christenson SD, Bae J, Van Lanen SG, Zazopoulos E, Farnet CM, Yang CF, Shen B: The neocarzinostatin biosynthetic gene cluster from Streptomyces carzinostaticus ATCC 15944 involving two iterative type I polyketide synthases. Chem Biol. 2005, 12: 293-302. 10.1016/j.chembiol.2004.12.013.PubMedView ArticleGoogle Scholar
- Van Lanen SG, Oh TJ, Liu W, Wendt-Pienkowski E, Shen B: Characterization of the maduropeptin biosynthetic gene cluster from Actinomadura madurae ATCC 39144 supporting a unifying paradigm for enediyne biosynthesis. J Am Chem Soc. 2007, 129: 13082-13094. 10.1021/ja073275o.PubMed CentralPubMedView ArticleGoogle Scholar
- Gao Q, Thorson JS: The biosynthetic genes encoding for the production of the dynemicin enediyne core in Micromonospora chersina ATCC53710. FEMS Microbiol Lett. 2008, 282: 105-114. 10.1111/j.1574-6968.2008.01112.x.PubMedView ArticleGoogle Scholar
- Bierman M, Logan R, O'Brien K, Seno ET, Rao RN, Schoner BE: Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp. Gene. 1992, 116: 43-49. 10.1016/0378-1119(92)90627-2.PubMedView ArticleGoogle Scholar
- Murrell JM, Liu W, Shen B: Biochemical characterization of the SgcA1 alpha-D-glucopyranosyl-1-phosphate thymidylyltransferase from the enediyne antitumor antibiotic C-1027 biosynthetic pathway and overexpression of sgcA1 in Streptomyces globisporus to improve C-1027 production. J Nat Prod. 2004, 67: 206-213. 10.1021/np0340403.PubMedView ArticleGoogle Scholar
- Christenson SD, Liu W, Toney MD, Shen B: A novel 4-methylideneimidazole-5-one-containing tyrosine aminomutase in enediyne antitumor antibiotic C-1027 biosynthesis. J Am Chem Soc. 2003, 125: 6062-6063. 10.1021/ja034609m.PubMedView ArticleGoogle Scholar
- Bibb MJ, White J, Ward JM, Janssen GR: The mRNA for the 23S rRNA methylase encoded by the ermE gene of Saccharopolyspora erythraea is translated in the absence of a conventional ribosome-binding site. Mol Microbiol. 1994, 14: 533-545. 10.1111/j.1365-2958.1994.tb02187.x.PubMedView ArticleGoogle Scholar
- Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA: Practical Streptomyces Genitics. 2000, Norwich: The John Innes FoundationGoogle Scholar
- Zhao CY, Wang YF, Lian RM, Gao RJ, Li DD: Microbiological assay of lidamycin. Chin J Antibiot. 2005, 30: 535-537.Google Scholar
- Sambrook J, Russell DW: Molecular Cloning: a Laboratory Manual. 2001, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 3Google Scholar
- Hong B, Phornphisutthimas S, Tilley E, Baumberg S, McDowall KJ: Streptomycin production by Streptomyces griseus can be modulated by a mechanism not associated with change in the adpA component of the A-factor cascade. Biotechnol Lett. 2007, 29: 57-64. 10.1007/s10529-006-9216-2.PubMedView ArticleGoogle Scholar
- Uguru GC, Stephens KE, Stead JA, Towle JE, Baumberg S, McDowall KJ: Transcriptional activation of the pathway-specific regulator of the actinorhodin biosynthetic genes in Streptomyces coelicolor. Mol Microbiol. 2005, 58: 131-150. 10.1111/j.1365-2958.2005.04817.x.PubMedView ArticleGoogle Scholar
- Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29: e45-10.1093/nar/29.9.e45.PubMed CentralPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.